Short Interest in NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Declines By 60.9%

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the recipient of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 73,200 shares, a drop of 60.9% from the November 15th total of 187,000 shares. Based on an average trading volume of 2,760,000 shares, the short-interest ratio is presently 0.0 days.

NovaBay Pharmaceuticals Price Performance

Shares of NYSEAMERICAN NBY traded up $0.02 during midday trading on Friday, reaching $0.57. 62,820 shares of the stock were exchanged, compared to its average volume of 917,828. The stock has a market capitalization of $2.42 million, a price-to-earnings ratio of -0.06 and a beta of 2.82. NovaBay Pharmaceuticals has a twelve month low of $0.36 and a twelve month high of $10.15.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.